back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-03-06 15:21 Tx date 2023-03-01 |
$BLCO
Bausch + Lomb Corporation |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
56 - Grant of rights
|
+56,689 vol |
56,689 | |
| Filed 2023-03-06 15:21 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-06 15:20 Tx date 2023-03-01 |
$BLCO
Bausch + Lomb Corporation |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+28,344 vol |
146,677 | |
| Filed 2023-03-06 15:20 Tx date 2023-03-01 |
$BLCO
Bausch + Lomb Corporation |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,744 vol |
420,414 | |
| Filed 2022-07-27 17:44 Tx date 2022-07-25 |
$BLCO
Bausch + Lomb Corporation |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+35,000 vol |
118,333 | |
| Filed 2022-05-12 08:13 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
329,670 | ||
| Filed 2022-05-12 08:12 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
83,333 | ||
| Filed 2022-03-11 16:15 Tx date 2022-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-18,927.84
-839 vol $22.56 each |
111,345 | |
| Filed 2022-03-11 16:14 Tx date 2022-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$33,005
+1,463 vol $22.56 each |
112,184 | |
| Filed 2022-03-11 16:13 Tx date 2022-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,463 vol |
50,895 | |
| Filed 2022-03-08 11:09 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-163,522.86
-6,926 vol $23.61 each |
110,721 | |
| Filed 2022-03-08 11:09 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$285,279
+12,083 vol $23.61 each |
117,647 | |
| Filed 2022-03-08 11:08 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-12,083 vol |
52,358 | |
| Filed 2022-03-03 17:18 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-73,196.10
-3,006 vol $24.35 each |
105,564 | |
| Filed 2022-03-03 17:17 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-66,792.05
-2,743 vol $24.35 each |
108,570 | |
| Filed 2022-03-03 17:16 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$172,982
+7,104 vol $24.35 each |
111,313 | |
| Filed 2022-03-03 17:14 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$157,861
+6,483 vol $24.35 each |
90,196 | |
| Filed 2022-03-03 17:12 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,104 vol |
64,441 | |
| Filed 2022-03-03 17:11 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-6,483 vol |
71,545 | |
| Filed 2022-03-03 16:55 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-250,293.65
-10,279 vol $24.35 each |
97,726 | |
| Filed 2022-03-03 16:53 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$591,510
+24,292 vol $24.35 each |
108,005 | |
| Filed 2022-03-03 16:52 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-24,292 vol |
49,613 | |
| Filed 2022-03-03 16:50 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+24,292 vol |
73,905 | |
| Filed 2021-09-01 12:25 Tx date 2021-08-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-145,242.15
-5,017 vol $28.95 each |
83,713 | |
| Filed 2021-09-01 12:23 Tx date 2021-08-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$271,840
+9,390 vol $28.95 each |
88,730 | |
| Filed 2021-09-01 12:23 Tx date 2021-08-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-9,390 vol |
78,028 | |
| Filed 2021-06-04 17:55 Tx date 2021-06-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-3,857,732.34
-121,198 vol $31.83 each |
79,340 | |
| Filed 2021-06-04 17:54 Tx date 2021-06-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$932,267
+60,853 vol $15.32 each |
200,538 | |
| Filed 2021-06-04 17:52 Tx date 2021-06-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$867,761
+60,345 vol $14.38 each |
139,685 | |
| Filed 2021-06-04 17:51 Tx date 2021-06-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-60,853 vol |
235,738 | |
| Filed 2021-06-04 17:48 Tx date 2021-06-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-60,345 vol |
296,591 | |
| Filed 2021-03-15 17:16 Tx date 2021-03-11 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-26,124.72
-796 vol $32.82 each |
79,340 | |
| Filed 2021-03-15 17:15 Tx date 2021-03-11 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$48,015
+1,463 vol $32.82 each |
80,136 | |
| Filed 2021-03-15 17:14 Tx date 2021-03-11 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,463 vol |
87,418 | |
| Filed 2021-03-11 18:00 Tx date 2021-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-724,021.20
-21,960 vol $32.97 each |
78,673 | |
| Filed 2021-03-11 17:58 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+6,819 vol |
100,633 | |
| Filed 2021-03-11 17:57 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+34,435 vol |
93,814 | |
| Filed 2021-03-11 17:56 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-6,819 vol |
88,881 | |
| Filed 2021-03-11 17:54 Tx date 2021-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-34,435 vol |
49,613 | |
| Filed 2021-03-05 18:32 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+26,364 vol |
84,048 | |
| Filed 2021-03-05 18:30 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+52,392 vol |
356,936 | |
| Filed 2021-03-05 18:28 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+36,250 vol |
95,700 | |
| Filed 2021-03-03 20:13 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-168,631.14
-5,367 vol $31.42 each |
59,379 | |
| Filed 2021-03-03 20:12 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$426,872
+13,586 vol $31.42 each |
64,746 | |
| Filed 2021-03-03 20:11 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-13,586 vol |
59,450 | |
| Filed 2020-09-01 16:47 Tx date 2020-08-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+28,171 vol |
73,036 | |
| Filed 2020-03-12 10:15 Tx date 2020-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+4,390 vol |
44,865 | |
| Filed 2020-03-12 10:14 Tx date 2020-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$80,105
+4,390 vol $18.25 each |
51,160 | |
| Filed 2020-03-12 10:12 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-70,069.28
-3,343 vol $20.96 each |
46,770 | |
| Filed 2020-03-12 10:12 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$142,926
+6,819 vol $20.96 each |
50,113 | |
| Filed 2020-03-12 10:11 Tx date 2020-03-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-142,926.24
-6,819 vol $20.96 each |
40,475 | |
| Filed 2020-03-11 17:02 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-92,358.76
-3,779 vol $24.44 each |
43,294 | |
| Filed 2020-03-11 17:01 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$173,597
+7,103 vol $24.44 each |
47,073 | |
| Filed 2020-03-11 17:00 Tx date 2020-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-173,597.32
-7,103 vol $24.44 each |
47,294 | |
| Filed 2020-03-11 16:16 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+12,966 vol |
57,684 | |
| Filed 2020-03-11 16:15 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+12,966 vol |
44,718 | |
| Filed 2020-03-11 16:13 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+81,873 vol |
304,544 | |
| Filed 2020-03-11 16:11 Tx date 2020-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+19,449 vol |
54,397 | |
| Filed 2020-02-28 17:32 Tx date 2020-02-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-592,121.88
-22,378 vol $26.46 each |
39,970 | |
| Filed 2020-02-28 17:31 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,118,384
+42,267 vol $26.46 each |
62,348 | |
| Filed 2020-02-28 17:30 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$208,081
+7,864 vol $26.46 each |
20,081 | |
| Filed 2020-02-28 17:29 Tx date 2020-02-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-16,384 vol |
31,752 | |
| Filed 2020-01-10 12:16 Tx date 2020-01-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-98,851.20
-3,360 vol $29.42 each |
12,217 | |
| Filed 2020-01-10 12:15 Tx date 2020-01-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$241,008
+8,192 vol $29.42 each |
15,577 | |
| Filed 2020-01-10 12:14 Tx date 2020-01-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-241,008.64
-8,192 vol $29.42 each |
34,948 | |
| Filed 2019-08-26 18:22 Tx date 2019-08-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-76,725.555
-3,418 vol $22.45 each |
7,385 | |
| Filed 2019-08-26 18:18 Tx date 2019-08-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-174,171.81
-7,779 vol $22.39 each |
10,803 | |
| Filed 2019-08-26 18:17 Tx date 2019-08-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$327,229
+14,615 vol $22.39 each |
18,582 | |
| Filed 2019-08-26 18:16 Tx date 2019-08-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-14,615 vol |
43,140 | |
| Filed 2019-07-23 19:39 Tx date 2019-07-11 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-98,446.08
-3,968 vol $24.81 each |
3,967 | |
| Filed 2019-07-23 19:36 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-73,227.50
-3,446 vol $21.25 each |
4,746 | |
| Filed 2019-07-23 19:33 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$174,080
+8,192 vol $21.25 each |
8,192 | |
| Filed 2019-07-23 19:32 Tx date 2019-01-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-8,192 vol |
43,264 | |
| Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-85,522.80
-3,630 vol $23.56 each |
3,189 | |
| Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-160,655.64
-6,819 vol $23.56 each |
65,947 | |
| Filed 2019-03-13 Tx date 2019-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$160,655
+6,819 vol $23.56 each |
6,819 | |
| Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+62,004 vol |
222,671 | |
| Filed 2019-03-12 Tx date 2019-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+21,310 vol |
72,766 | |
| Filed 2018-10-18 Tx date 2018-10-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-382,481.32
-15,404 vol $24.83 each |
4,542 | |
| Filed 2018-10-18 Tx date 2018-10-16 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-115,821
-4,542 vol $25.50 each |
0 | |
| Filed 2018-08-15 Tx date 2018-08-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-182,962.08
-7,779 vol $23.52 each |
19,946 | |
| Filed 2018-08-15 Tx date 2018-08-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$343,744
+14,615 vol $23.52 each |
27,725 | |
| Filed 2018-08-15 Tx date 2018-08-09 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-14,615 vol |
51,456 | |
| Filed 2018-03-14 Tx date 2018-03-07 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+13,638 vol |
48,136 | |
| Filed 2018-03-14 Tx date 2018-03-07 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+20,457 vol |
66,071 | |
| Filed 2018-03-14 Tx date 2018-03-07 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$932,267
+60,853 vol $15.32 each |
160,667 | |
| Filed 2018-01-10 Tx date 2018-01-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-8,191 vol |
45,614 | |
| Filed 2018-01-10 Tx date 2018-01-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-87,028.65
-3,649 vol $23.85 each |
13,110 | |
| Filed 2018-01-10 Tx date 2018-01-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$195,355
+8,191 vol $23.85 each |
16,759 | |
| Filed 2017-08-14 Tx date 2016-08-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-14 Tx date 2017-08-09 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-92,927.02
-6,046 vol $15.37 each |
8,568 | |
| Filed 2017-08-14 Tx date 2017-08-09 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$224,617
+14,614 vol $15.37 each |
14,614 | |
| Filed 2017-08-14 Tx date 2017-08-09 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-14,614 vol |
53,805 | |
| Filed 2017-03-06 Tx date 2017-03-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$867,761
+60,345 vol $14.38 each |
99,814 | |
| Filed 2017-01-11 Tx date 2017-01-06 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+8,192 vol |
34,498 | |
| Filed 2017-01-11 Tx date 2017-01-06 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+24,575 vol |
68,419 | |
| Filed 2016-08-15 Tx date 2016-08-10 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+39,469 vol |
39,469 | |
| Filed 2016-08-15 Tx date 2016-08-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-08-12 Tx date 2016-08-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+26,306 vol |
||
| Filed 2016-08-12 Tx date 2016-08-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$600,039
+26,306 vol $22.81 each |
26,306 | |
| Filed 2016-08-12 Tx date 2016-08-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+43,844 vol |
43,844 | |
| Filed 2016-08-11 Tx date 2016-08-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-08-11 Tx date 2016-08-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|